Business Wire

SEKISUI-HOUSE

30.11.2022 12:57:44 CET | Business Wire | Press release

Share
The University of Tokyo and Sekisui House Launch Joint Research on Biodiversity and Health

The Graduate School of Agricultural and Life Sciences (GSALS) at the University of Tokyo and Sekisui House, Ltd. will launch a joint research project on biodiversity and human health on December 1, 2022. The project will investigate the benefits that biodiversity and urban natural environments have on human health and wellbeing. This will be the world’s first initiative to comprehensively investigate the effects of interacting with the nearby nature of a garden rich in biodiversity on the health of residents and their attitudes and behavior toward nature.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20221129006146/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Application of Sekisui House’s Gohon no Ki concept to detached homes (Photo: Business Wire)

The Laboratory of Conservation Ecology1, Department of Ecosystem Studies, GSALS at the University of Tokyo conducts research on the conservation of urban biodiversity and the management of ecosystem services (the benefits to human society provided by ecosystems). The Laboratory has been studying the relationship between nature and human health since 2016, and its research indicates that interactions with nature can lead to improved human health and wellbeing. However, the question of how these health benefits might vary depending on the quality rather than the quantity of nature has not yet been explored.

In 2020, the Laboratory of Conservation Ecology at the University of Tokyo’s GSALS investigated how two means of interacting with nature—the frequency of green space use and viewing greenery from the windows of homes—affect the mental health of urban residents (self-esteem, life satisfaction, happiness, symptoms of depression/anxiety, and loneliness). The results of this research showed that not only people who frequently use green spaces, but also those who live in houses with green view reported better mental health.² This suggests that people can benefit from the psychological effects of nature from within their own homes even if they are not physically present in green spaces.

In the attached chart, the magnitude of positive (right of the dashed line) and negative (left of the dashed line) effects indicates that each factor has a positive or negative relationship with each mental health measures. For example, “green view” is associated with low levels of depression and anxiety symptoms, while “impact of COVID-19 on income” is associated with high levels of such symptoms. Analysis of the results showed that experiencing nature can affect mental health to the same degree as factors such as income that have been traditionally regarded as important to mental health. 

Since 2001, Sekisui House has been pursuing the conservation of biodiversity by creating green networks in urban residential districts under its Gohon no Ki Project, a proposal for creating gardens and communities with native tree species of the region concerned. Joint research conducted with the University of the Ryukyu’s Kubota Laboratory and Think Nature Inc. since 2019 has revealed that this focus on planting native garden trees in line with the Gohon no Ki Project has increased biodiversity in urban areas (Japan’s three major metropolitan areas) where biodiversity has declined significantly.

The new joint research project will combine analytical methods developed by the Laboratory of Conservation Ecology at the University of Tokyo’s GSALS with Sekisui House’s Gohon no Ki Project to conserve biodiversity in what is the first attempt worldwide to scientifically investigate the effects of biodiverse garden greenery on human health and wellbeing. This research will also aim to demonstrate the importance from the perspective of biodiversity of creating gardens rich in biodiversity rather than simply “greenery.”

The Laboratory of Conservation Ecology at the University of Tokyo’s GSALS is conducting research to test five hypotheses regarding the relationship between human health and interactions with nature under the themes of mental health, physical health, cognitive functions, and community health. For the time being, the new joint research project will focus on two hypotheses related to mental health, and one hypothesis related to cognitive functions. This is, however, a long-term joint research project that will later also look at community health and other themes related to health.

Hypotheses

Theme

Hypothesis

Mental health

1

People who interact with nature in the garden have fewer negative emotions (depression, anxiety symptoms, stress, etc.) and more positive emotions (quality of life, happiness, etc.).

2

People who can view nature through their windows have better mental health.

Cognitive functions

3

Interacting with nature in the garden improves cognitive functions.

Community health

4

Interacting with nature in the garden contributes to community health.

Physical health

5

Exercising in natural surroundings offers more health benefits than indoor exercise.

University of Tokyo GSALS Associate Professor Masashi Soga has commented as follows regarding this joint research project.

“People have always turned to nature for relaxation and tranquility, and recent advances in research and technology have made it possible to quantify such intangible health benefits. However, very little is known about the role played by biodiversity in providing these health benefits. If we could shed light on this topic, we may be able to develop the kind of landscape and green space management that supports coexistence with nature because it is desirable from the perspectives of both conserving biodiversity and enhancing human health.

This joint research project is a large-scale investigation of how interacting with nature in our gardens, perhaps the most familiar nature to most of us, affects our health and well-being. Garden biodiversity is an area that has been difficult to study up to now, but Sekisui House’s nationwide planting data will enable us to conduct the world’s first comprehensive investigation into the relationship between garden biodiversity and human health, and the way people appreciate and interact with nature. Up until now, discussions on the health benefits of nature have tended to focus on relatively large expanses of greenery such as green spaces and forests, but with this new study, we hope to shed light on the importance of actually ‘living with nature.’ Our research outcomes will hopefully be useful to promoting the conservation of urban biodiversity.”

The University of Tokyo GSALS and Sekisui House aim to contribute to the conservation of urban biodiversity and creation of a nature-positive society by sharing the findings of the investigation of the way in which interactions with nearby nature in urban environments affects people’s mental health and the way they appreciate and interact with nature.

Notes

  1. Graduate School of Agricultural and Life Sciences, University of Tokyo, Soga Laboratory: https://www.masashi-soga.com/
  2. A room with a green view: the importance of nearby nature for mental health during the COVID-19 pandemic: https://esajournals.onlinelibrary.wiley.com/doi/10.1002/eap.2248
  3. Sekisui House biodiversity conservation initiative: https://www.sekisuihouse.co.jp/gohon_sp/
  4. Sekisui House’s nature-positive methodology: https://www.sekisuihouse.co.jp/gohon_sp/method/

Graduate School of Agricultural and Life Sciences, University of Tokyo

The University of Tokyo’s Graduate School of Agricultural and Life Sciences provides a step-by-step, systematic education in applied sciences within the field of agriculture. Through its educational and research activities, it aims to nurture people with the kind of insight, practical abilities, and leadership qualities required to address the needs of global society through social, cultural, and industrial activities.

Sekisui House’s Gohon no Ki Project

The Gohon no Ki Project was launched by Sekisui House in 2001 as an initiative to conserve biodiversity through the eco-friendly landscaping and greening of the gardens of its customers with their cooperation. Based on the concept of planting five locally native trees, three for birds and two for butterflies, and using traditional Japanese satoyama landscape as a model, the Gohon no Ki Project proposes greening gardens and local communities with native tree species suited to the local climate and benevolent to birds, butterflies, and other local fauna. In fiscal 2021, Sekisui House planted 1.01 million trees, bringing the number of trees planted since the Gohon no Ki Project was launched in 2001 to 18.1 million trees (as of January 2022). Since 2019, the company has been working with the University of the Ryukyu’s Kubota Laboratory and Think Nature Co., Ltd. to quantitatively evaluate the contribution of network-type greening to urban biodiversity. In 2021, it developed the world’s first mechanism for quantitatively evaluating urban biodiversity using big data on tree numbers, species, location data, and ecosystems to determine the effectiveness of biodiversity conservation, publishing it as the “nature-positive methodology.”

Graduate School of Agricultural and Life Sciences, University of Tokyo Soga Laboratory Data

  1. Soga et al. (2017) Gardening is beneficial for health: a meta-analysis. Preventive Medicine Reports, 5, 92-99.
    URL: https://www.sciencedirect.com/science/article/pii/S2211335516301401
    Overview: A meta-analysis (statistical analysis that combines the results of multiple scientific studies and analyzes whether a certain factor is related to a specific issue) that confirmed that interaction with plants through gardening has positive effects on human health
  2. Soga, Gaston (2016) Extinction of experience: the loss of human-nature interactions. Frontiers in Ecology and the Environment, 14, 94-101.
    URL : https://esajournals.onlinelibrary.wiley.com/doi/full/10.1002/fee.1225
    Overview: A study showing that human interaction with nature is declining in many developed countries, and that this “extinction of experience” may have serious negative implications for human health and the protection of ecosystems
  3. Soga et al. (2020) How can we mitigate against increasing biophobia among children during the extinction of experience? Biological Conservation, 242, 108420.
    URL: https://www.sciencedirect.com/science/article/pii/S0006320719309577
    Overview: A study showing that people who interact with nature only infrequently are more likely to show negative reactions (fear, disgust) toward common insects and other invertebrates

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20221129006146/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

New Auction Record Set as Falcon Sells for AED 1.5 Million at ADIHEX 202629.8.2026 23:54:00 CEST | Press release

Qarmousha Pure Ultra White falcon sells for AED 1.5 million at the Abu Dhabi International Hunting and Equestrian Exhibition 2026 (ADIHEX) falcon auction Under the patronage of His Highness Sheikh Hamdan bin Zayed Al Nahyan, Ruler’s Representative in Al Dhafra Region and Chairman of the Emirates Falconers’ Club, the fifth auction held as part of the 23rd edition of the Abu Dhabi International Hunting and Equestrian Exhibition (ADIHEX) 2026 attracted remarkable turnout, culminating in the sale of a Qarmousha Pure Ultra White falcon for AED 1.5 million (USD 408,000). The sale marks the highest price achieved at any auction during this year’s edition of the exhibition. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260829032621/en/ Qarmousha Pure Ultra White (Photo: AETOSWire) This forms part of the largest auction programme in the exhibition’s history, held under the theme “A Legacy of Pride,” organised by ADNEC Group, a Modon

Takeda Receives U.S. FDA Approval of MIMRYLO™ (rusfertide), Marking a Potential Shift in the Treatment Paradigm for Polycythemia Vera29.8.2026 00:40:00 CEST | Press release

MIMRYLO, a First-in-Class Medicine with a Unique Mechanism of Action, is Approved for the Treatment of Erythrocytosis in Adults with Polycythemia Vera (PV)MIMRYLO Has Been Shown to Maintain Hematocrit Control, the Primary Treatment Goal in PV, as Well as Reduce Phlebotomy Burden and Improve FatigueApproval Supported by Phase 3 VERIFY Results Showing 76.9% of Patients Achieved Clinical Response During Weeks 20-32 Takeda (TSE:4502/NYSE:TAK)announced U.S. Food and Drug Administration (FDA) approval of the New Drug Application (NDA)* for MIMRYLO™ (rusfertide) for the treatment of erythrocytosis in adults with polycythemia vera (PV), a blood cancer. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260824773270/en/ MIMRYLO Logo MIMRYLO is a first-in-class hepcidin mimetic designed to regulate iron distribution in the body and red blood cell overproduction to control hematocrit levels, which is the ratio of red blood cells to the tot

Rigaku and Tohoku University Establish a New Research Institute for X-Ray Metrology28.8.2026 16:00:00 CEST | Press release

Rigaku Corporation, a group company of Rigaku Holdings and a global solutions partner for X-ray analytical systems (Head Office: Akishima, Tokyo; President and CEO: Jun Kawakami; “Rigaku”), and Tohoku University (Sendai, Miyagi; President: Teiji Tominaga; “Tohoku University”) have established the Rigaku-Tohoku University Co-Creation Research Institute for X-ray Metrology: Beyond The Limits (the “Institute”) at Tohoku University on August 1, 2026. The Institute will advance X-ray metrology technology, develop new metrology methods, and foster the next generation of researchers through an initial three-year collaboration, with the possibility of extension based on its achievements. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260828688510/en/ Inside the Institute As semiconductors become smaller, more multilayered, and incorporate a wider range of materials, manufacturing processes are becoming increasingly complex. X-ray me

BLK: Portfolio Company of Enry’s Island S.p.A., Lists on Euronext Dublin28.8.2026 15:34:00 CEST | Press release

Enry’s Island S.p.A. (WBAG:EIOS), an international venture builder with headquarters in the Tremiti Islands and the Metaverse, announces that BLK Global PLC, one of the portfolio companies within its ecosystem, has successfully completed its admission to trading on Euronext Access Dublin. Trading in the company’s shares commenced on Friday, July 31, 2026, under ticker BLKX and ISIN GB00BPSKS130. BLK was one of the thousands of applications received by Enry’s Island which, following an assessment process based on the Enry’s Model, was selected for a one-year incubation and acceleration programme. The programme supported the company through its subsequent growth stages, ultimately leading to its current stock market listing. Alessandro Pacciana, Investor Relations Manager of Enry’s Island S.p.A., said: “BLK’s listing is the second stock market listing in two years among Enry’s Island’s portfolio companies, while Enry’s Island itself is the world’s first listed venture builder. We are pro

Zambon Announces European Commission Approval of Hopledo® for Adults with Parkinson's Disease and Moderate to Severe Motor Fluctuations28.8.2026 11:00:00 CEST | Press release

Hopledo® is a first-in-class, oral, modified-release formulation of levodopa/carbidopa (LD/CD) approved for the treatment of motor fluctuations of Parkinson’s disease Zambon expects to begin the phased introduction of Hopledo® across European markets starting October 2026 The approval is based on data from the Phase 3 RISE-PD trial where Hopledo® demonstrated a significant increase in Good ON time compared with immediate-release LD/CD with fewer daily doses and a comparable safety profile Zambon today announced that the European Commission (EC) has granted marketing authorization for Hopledo® (modified-release levodopa/carbidopa) for the treatment of adult patients with Parkinson’s disease and moderate to severe motor fluctuations who have not been sufficiently stabilized with oral levodopa/dopa decarboxylase (DDC) inhibitor-based treatment regimens. Zambon expects to begin the phased introduction of Hopledo® across European markets starting October 2026. The company is working closely

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye